Oncotarget
The cover for issue 71 of Oncotarget features Figure 1B, "Schematic representation to illustrate the differential binding and internalization of low affinity EGFR-ADC on normal cells versus tumor cells that express higher level of the receptors," by Wong, et al.
CXCR4 antagonists for treatment of breast cancer |
https://doi.org/10.18632/oncotarget.26090 Javier Cortés, Esther Holgado, and Jose Perez-Garcia |
33442-33443 |
PDF | How to cite | Order a Reprint |
Boosting chemokine receptor recycling: an elixir of life for chronic lymphocytic leukemia |
https://doi.org/10.18632/oncotarget.26099 Laura Patrussi, and Cosima T. Baldari |
33444-33445 |
PDF | How to cite | Order a Reprint |
RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models |
https://doi.org/10.18632/oncotarget.26002 Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, Meritxell Galindo Casas, Melinda Au, Marjorie Bateman, Kevin C. Lindquist, Arvind Rajpal, David L. Shelton, Pavel Strop, and Shu-Hui Liu |
33446-33458 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Press Release | Order a Reprint |
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer |
https://doi.org/10.18632/oncotarget.9663 Mohamad Elbaz, Dinesh Ahirwar, Zhang Xiaoli, Xinyu Zhou, Maryam Lustberg, Mohd W. Nasser, Konstantin Shilo, and Ramesh K. Ganju |
33459-33470 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme |
https://doi.org/10.18632/oncotarget.26033 Ramon Martinez-Olivera, Angeliki Datsi, Maren Stallkamp, Manfred Köller, Isabelle Kohtz, Bogdan Pintea, and Konstantinos Gousias |
33471-33481 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Generation and characteristics of a novel “double-hit” high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies |
https://doi.org/10.18632/oncotarget.26060 Hiroaki Kikuchi, Tomonori Higuchi, Yumiko Hashida, Ayuko Taniguchi, Mikio Kamioka, Takahiro Taguchi, Akihito Yokoyama, Ichiro Murakami, Mikiya Fujieda, and Masanori Daibata |
33482-33499 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Comparative proteomic analysis of cat eye syndrome critical region protein 1- function in tumor-associated macrophages and immune response regulation of glial tumors |
https://doi.org/10.18632/oncotarget.26063 Changbin Zhu, Dana A.M. Mustafa, Merle M. Krebber, Ihsan Chrifi, Pieter J.M. Leenen, Dirk J. Duncker, Lennard Dekker, Theo M. Luider, Johan M. Kros, and Caroline Cheng |
33500-33514 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk |
https://doi.org/10.18632/oncotarget.26067 Masashi Muramatsu, Shin Akakura, Lingqiu Gao, Jennifer Peresie, Benjamin Balderman, and Irwin H. Gelman |
33515-33527 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies |
https://doi.org/10.18632/oncotarget.26083 Patrice Chevallier, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, Thomas Gastinne, Anne Lok, Yannick Le Bris, Marie C. Béné, Steven Le Gouill, Philippe Moreau, and Thierry Guillaume |
33528-33535 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Intestinal epithelial Notch-1 protects from colorectal mucinous adenocarcinoma |
https://doi.org/10.18632/oncotarget.26086 David Dunkin, Alina C. Iuga, Sanda Mimouna, Carolyn L. Harris, Jean-Vianney Haure-Mirande, Dominique Bozec, Garabet Yeretssian, and Stephanie Dahan |
33536-33548 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma |
https://doi.org/10.18632/oncotarget.26088 Hisham F. Bahmad, Tarek H. Mouhieddine, Reda M. Chalhoub, Sahar Assi, Tarek Araji, Farah Chamaa, Muhieddine M. Itani, Amaly Nokkari, Firas Kobeissy, Georges Daoud, and Wassim Abou-Kheir |
33549-33561 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines |
https://doi.org/10.18632/oncotarget.26093 Moses Koobotse, Jeff Holly, and Claire Perks |
33562-33576 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer |
https://doi.org/10.18632/oncotarget.26094 Michael J.G. Milevskiy, Gurveen K. Sandhu, Anna Wronski, Darren Korbie, Brooke L. Brewster, Annette Shewan, Stacey L. Edwards, Juliet D. French, and Melissa A. Brown |
33577-33588 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells |
https://doi.org/10.18632/oncotarget.26096 Tasaduq H. Wani, Sreeraj Surendran, Vishnu S. Mishra, Jaya Chaturvedi, Goutam Chowdhury, and Anindita Chakrabarty |
33589-33600 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study |
https://doi.org/10.18632/oncotarget.26035 Md. Jakaria, Md. Ezazul Haque, Joonsoo Kim, Duk-Yeon Cho, In-Su Kim, and Dong-Kug Choi |
33601-33620 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC